In Vitro and In Vivo Evaluation of Epidermal Growth Factor (EGF) Loaded Alginate-Hyaluronic Acid (AlgHA) Microbeads System for Wound Healing
Source abstract
Abstract
The management of skin injuries is one of the most common concerns in medical facilities. Different types of biomaterials with effective wound-healing characteristics have been studied previously. In this study, we used alginate (Alg) and hyaluronic acid (HA) composite (80:20) beads for the sustained release of epidermal growth factor (EGF) delivery. Heparin crosslinked AlgHA beads showed significant loading and entrapment of EGF. Encapsulated beads demonstrated biocompatibility with rat L929 cells and significant migration at the concentration of AlgHAEGF100 and AlgHAEGF150 within 24 h. Both groups significantly improved the expression of Fetal Liver Kinase 1 (FLK-1) along with the Intercellular Adhesion Molecule-1 (ICAM-1) protein in rat bone Mesenchymal stem cells (rbMSCs). In vivo assessment exhibited significant epithelialization and wound closure gaps within 2 weeks. Immunohistochemistry shows markedly significant levels of ICAM-1, FLK-1, and fibronectin (FN) in the AlgHAEGF100 and AlgHAEGF150 groups. Hence, we conclude that the EGF-loaded alginate-hyaluronic acid (AlgHA) bead system can be used to promote wound healing.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Surgical Sutures and Adhesives · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Regenerative Medicine, College of Medicine, Soonchunhyang University, Cheonan 31538, Republic of Korea
Department of Plastic and Reconstructive Surgery, College of Medicine, Soonchunhyang University, Cheonan 31538, Republic of Korea
Funding
National Research Foundation of Korea (NRF) · Soonchunhyang University research fund
References (84)
Show source-provided references
1. Corneal cells: Chatty in development, homeostasis, wound healing, and disease10.1016/S0002-9394(03)00085-0 ↗
2. New method for assessing epidermal wound healing: The effects of triamcinolone acetonide and polyethelene film occlusion10.1111/1523-1747.ep12556814 ↗
3. Wound repair and regeneration10.1159/000339613 ↗
4. Riha, S.M., Maarof, M., and Fauzi, M.B. (2021). Synergistic effect of biomaterial and stem cell for skin tissue engineering in cutaneous wound healing: A concise review. Polymers, 13.10.3390/polym13101546 ↗
5. Biomaterial-based cell delivery strategies to promote liver regeneration10.1186/s40824-021-00206-w ↗
6. Design of epidermal growth factor immobilization on 3D biocompatible scaffolds to promote tissue repair and regeneration10.1038/s41598-021-81905-1 ↗
7. Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin10.1016/j.biomaterials.2005.04.012 ↗
8. Multifunctional alginate fibres with anti-bacterial properties
9. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules10.1016/S0142-9612(96)00135-4 ↗
10. Degradation of partially oxidized alginate and its potential application for tissue engineering10.1021/bp010070p ↗
11. Mussel-inspired dual-cross-linking hyaluronic acid/ε-polylysine hydrogel with self-healing and antibacterial properties for wound healing10.1021/acsami.0c00782 ↗
12. Antibacterial anti-oxidant electroactive injectable hydrogel as self-healing wound dressing with hemostasis and adhesiveness for cutaneous wound healing10.1016/j.biomaterials.2017.01.011 ↗
13. Biocompatible and biodegradable poly (Tannic Acid) hydrogel with antimicrobial and antioxidant properties10.1016/j.ijbiomac.2015.10.057 ↗
14. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing10.1084/jem.176.5.1375 ↗
15. Growth factors: Importance in wound healing and maintenance of transparency of the cornea10.1016/S1350-9462(99)00007-5 ↗
16. Smad-dependent and Smad-independent pathways in TGF-β family signalling10.1038/nature02006 ↗
17. Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: Different mechanisms are responsible for the regulation of BDNF and NGF mRNA10.1083/jcb.119.1.45 ↗
18. Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse10.1242/dev.114.3.755 ↗
19. Solid-phase aggregation of proteins under pharmaceutically relevant conditions10.1002/jps.2600831205 ↗
20. Construction of a novel extracellular matrix using a new genetically engineered epidermal growth factor fused to IgG-Fc10.1007/s10529-005-2605-0 ↗
21. Protein A immobilized affinity cartridge for immunoglobulin purification10.1111/j.1470-8744.1991.tb00154.x ↗
22. Natural and synthetic biomaterials for controlled drug delivery10.1007/s12272-013-0280-6 ↗
23. Thermal degradation of SBS in bitumen during storage: Influence of temperature, SBS concentration, polymer type and base bitumen10.1016/j.polymdegradstab.2017.11.008 ↗
24. Controlled release of vascular endothelial growth factor (VEGF) in alginate and hyaluronic acid (ALG–HA) bead system to promote wound healing in punch-induced wound rat model10.1080/09205063.2022.2135264 ↗
25. In vivo printing of growth factor-eluting adhesive scaffolds improves wound healing10.1016/j.bioactmat.2021.06.030 ↗
26. Promotion of skin regeneration through co-axial electrospun fibers loaded with basic fibroblast growth factor10.1007/s42114-022-00439-w ↗
27. Emulsion-alginate beads designed to control in vitro intestinal lipolysis: Towards appetite control10.1016/j.jff.2017.05.003 ↗
28. Kurowiak, J., Kaczmarek-Pawelska, A., Mackiewicz, A.G., and Bedzinski, R. (2020). Analysis of the degradation process of alginate-based hydrogels in artificial urine for use as a bioresorbable material in the treatment of urethral injuries. Processes, 8.10.3390/pr8030304 ↗
29. The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering10.1016/j.biomaterials.2009.12.053 ↗
30. NIH Image to ImageJ: 25 years of image analysis10.1038/nmeth.2089 ↗
31. Immobilization of Brassica oleracea chlorophyllase 1 (BoCLH1) and Candida rugosa lipase (CRL) in magnetic alginate beads: An enzymatic evaluation in the corresponding proteins10.3390/molecules190811800 ↗
32. Incorporation of alginate-hyaluronic acid microbeads in injectable calcium phosphate cement for improved bone regeneration10.1016/j.matlet.2020.127830 ↗
33. Modulated protein delivery to engineer tissue repair10.1089/ten.tea.2019.0066 ↗
34. PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor10.1163/156856206774879090 ↗
35. Effect of EGF and bFGF on fibroblast proliferation and angiogenic cytokine production from cultured dermal substitutes10.1163/092050611X580463 ↗
36. In situ sodium alginate-hyaluronic acid hydrogel coating method for clinical applications10.1007/s13233-014-2001-5 ↗
37. Biodegradable hydrogel-based biomaterials with high absorbent properties for non-adherent wound dressing10.1111/iwj.12762 ↗
38. Recombinant human epidermal growth factor combined with vacuum sealing drainage for wound healing in Bama pigs
39. Independent of ErbB1 gene copy number, EGF stimulates migration but is not associated with cell proliferation in non-small cell lung cancer10.1186/1475-2867-13-38 ↗
40. Shamel, M., Mansy, M., and Mubarak, R. (2020). The Effect of EGF on VEGF Expression on Submandibular Salivary Gland of Albino Rats Receiving Doxorubicin. Egypt. J. Histol.
41. Nicolas, S., Abdellatef, S., Haddad, M.A., Fakhoury, I., and El-Sibai, M. (2019). Hypoxia and EGF stimulation regulate VEGF expression in human glioblastoma multiforme (GBM) cells by differential regulation of the PI3K/Rho-GTPase and MAPK pathways. Cells, 8.10.3390/cells8111397 ↗
42. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate10.1002/j.1939-4640.2001.tb02199.x ↗
43. Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies10.1002/ijc.21479 ↗
44. Epidermal growth factor receptor signaling to Erk1/2 and STATs control the intensity of the epithelial inflammatory responses to rhinovirus infection10.1074/jbc.M710257200 ↗
45. Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasion10.1074/jbc.A114.499020 ↗
46. A PEG-Lysozyme hydrogel harvests multiple functions as a fit-to-shape tissue sealant for internal-use of body10.1016/j.biomaterials.2018.10.047 ↗
47. Experimental study of epidermal growth factor and acidic fibroblast growth factor in the treatment of diabetic foot wounds
48. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression10.1016/S0002-9440(10)64534-8 ↗
49. Fibronectin precoating wound bed enhances the therapeutic effects of autologous epidermal basal cell suspension for full-thickness wounds by improving epidermal stem cells’ utilization10.1186/s13287-019-1236-7 ↗
50. Encapsulation of Satureja khuzistanica extract in alginate hydrogel accelerate wound healing in adult male rats10.1186/s41232-019-0090-4 ↗
51. A self-setting iPSMSC-alginate-calcium phosphate paste for bone tissue engineering10.1016/j.dental.2015.11.019 ↗
52. Examination of in vitro and in vivo biocompatibility of alginate-hyaluronic acid microbeads as a promising method in cell delivery for kidney regeneration10.1016/j.ijbiomac.2017.07.019 ↗
53. Bone regeneration of multichannel biphasic calcium phosphate granules supplemented with hyaluronic acid10.1016/j.msec.2019.02.051 ↗
54. Davison, N.L., Barrère-de Groot, F., and Grijpma, D.W. (2014). Degradation of biomaterials. Tissue Eng., 177–215.10.1016/B978-0-12-420145-3.00006-7 ↗
55. Yoshimi, Y., Oino, D., Ohira, H., Muguruma, H., Moczko, E., and Piletsky, S.A. (2019). Size of heparin-imprinted nanoparticles reflects the matched interactions with the target molecule. Sensors, 19.10.3390/s19102415 ↗
56. Glycosaminoglycans: Key players in cancer cell biology and treatment10.1111/j.1742-4658.2012.08529.x ↗
57. Heparin crosslinked chitosan microspheres for the delivery of neural stem cells and growth factors for central nervous system repair10.1016/j.actbio.2013.02.043 ↗
58. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.0.CO;2-N ↗
59. Crosslinking heparin to collagen scaffolds for the delivery of human platelet-derived growth factor10.1002/jbm.b.31411 ↗
60. Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems10.1016/j.jconrel.2007.04.019 ↗
61. Glycosaminoglycan: A candidate to stimulate the repair of chronic wounds10.1160/TH04-12-0812 ↗
62. The potential role of heparin in assisted conception10.1093/humupd/dmn031 ↗
63. Heparin-induced thrombocytopenia10.1056/NEJMcp1411910 ↗
64. Aging and heparin-related bleeding10.1001/archinte.1996.00440080047006 ↗
65. A novel function of angiotensin II in skin wound healing: Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation10.1074/jbc.M509771200 ↗
66. Heparin10.1056/NEJM199105303242206 ↗
67. Bioinspired heparin nanosponge prepared by photo-crosslinking for controlled release of growth factors10.1038/s41598-017-14040-5 ↗
68. Dynamics of controlled release of heparin from swellable crosslinked starch microspheres10.1007/s10856-007-3020-y ↗
69. Acceleration of partial-thickness burn wound healing with topical application of heparin-binding EGF-like growth factor (HB-EGF)10.1097/00004630-199803000-00002 ↗
70. Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells10.1007/s00280-007-0674-6 ↗
71. Epidermal growth factor-containing wound closure enhances wound healing in non-diabetic and diabetic rats10.1111/j.1742-481X.2009.00584.x ↗
72. New strategies in colorectal cancer: Biomarkers of response to epidermal growth factor receptor monoclonal antibodies and potential therapeutic targets in phosphoinositide 3-kinase and mitogen-activated protein kinase pathways10.1158/1078-0432.CCR-09-2283 ↗
73. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression10.1158/0008-5472.CAN-05-3589 ↗
74. Amphiregulin regulates odontogenic differentiation of dental pulp stem cells by activation of mitogen-activated protein kinase and the phosphatidylinositol 3-kinase signaling pathways10.1186/s13287-022-02971-4 ↗
75. Enhancement of epidermal regeneration by biosynthetic epidermal growth factor10.1084/jem.163.5.1319 ↗
76. Epidermal growth factor loaded heparin-based hydrogel sheet for skin wound healing10.1016/j.carbpol.2016.03.072 ↗
77. Mouse Metanephric Mesenchymal Cell–Derived Angioblasts Undergo Vasculogenesis in Three-Dimensional Culture10.1016/j.ajpath.2017.10.022 ↗
78. Induction by IL 1 and interferon-gamma: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)10.4049/jimmunol.137.1.245 ↗
79. Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors10.1111/1523-1747.ep12605923 ↗
80. Serum exosomes accelerate diabetic wound healing by promoting angiogenesis and ECM formation10.1002/cbin.11627 ↗
81. Human epidermal growth factor and the proliferation of human fibroblasts10.1002/jcp.1040880212 ↗
82. Variants of 3T3 cells lacking mitogenic response to epidermal growth factor10.1073/pnas.74.9.3918 ↗
83. 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts10.1083/jcb.71.1.159 ↗
84. A steady state model for analyzing the cellular binding, internalization and degradation of polypeptide ligands10.1016/0092-8674(81)90061-1 ↗